Aclaris Therapeutics
ACRS
ACRS
97 hedge funds and large institutions have $217M invested in Aclaris Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
51.16% more ownership
Funds ownership: 71.33% → 122.49% (+51%)
21% more funds holding
Funds holding: 80 → 97 (+17)
4% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 24
Holders
97
Holding in Top 10
2
Calls
$850K
Puts
$372K
Top Buyers
| 1 | +$23.9M | |
| 2 | +$22M | |
| 3 | +$11.6M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$8.56M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.99M |
Top Sellers
| 1 | -$4.45M | |
| 2 | -$2.6M | |
| 3 | -$2.2M | |
| 4 |
Renaissance Technologies
New York
|
-$1.29M |
| 5 |
BlackRock
New York
|
-$1.13M |